Tumor Necrosis Factor-alfa (TNF) is a cytokine that inhibits cell proliferation and prolactin release from anterior pituitary cells. TNF release as well as TNF effects are higher in anterior pituitary cells from proestrus rats and are estrogen-dependent. Also, TNF induces death by apoptosis in anterior pituitary cells, specially in lactotropes and somatotropes. The major goal of the present project is to determine the mechanisms involved in anterior pituitary cell renewal, in particular the role of TNF/TNF-R1 and the Fas/FasL systems in cell death by apoptosis in the anterior pituitary during the estrous cycle. First, we will evaluate whether apoptosis of anterior pituitary cells is induced by TNF-R1 and Fas activation. Then, we will explore the effect of TNF/TNF-R1 and Fas/FasL system son anterior pituitary cell apoptosis during the estrous cycle. In order to investigate whether TNF and FasL effects are directly exerted on lactotropes and somatotropes or mediated by paracrine actions on other cell types, we will localize the presence of TNF-R1, Fas and FasL in different anterior pituitary cell subpopulations by inmmunofluorescence. The expression of TNF-R1, Fas and FasL during the estrous cycle as well as the modulation of TNF-R1, Fas and FasL gene expression by gonadal steroids will also be investigated. Further, we will study the influence of gonadal steroids on the induction of apoptosis of anterior pituitary cells by theTNF/TNF-R1 and Fas/FasL systems. We will as well examine the influence of gonadal steroids on TNF- and Fas induced apoptosis by infecting anterior pituitary cells with adenoviral vectors expressing TNF or FasL. This research will be done primarily in Argentina at Buenos Aires University in collaboration with Adriana Seilicovich as a complement of an NIH grant. The experiments involving the generation, purification and characterization of recombinant adenovirus vectors will be performed at the Gene Therapeutics Institute, Cedars-Sinai Medical Center, LA. The same applyies for the viral infections of anterior pituitary cells in primary cultutre, their implementation, analysis of the data and interpretation of the results.

Agency
National Institute of Health (NIH)
Institute
Fogarty International Center (FIC)
Type
Small Research Grants (R03)
Project #
5R03TW006273-02
Application #
6847448
Study Section
International and Cooperative Projects 1 Study Section (ICP)
Program Officer
Michels, Kathleen M
Project Start
2004-03-01
Project End
2007-02-28
Budget Start
2005-03-01
Budget End
2006-02-28
Support Year
2
Fiscal Year
2005
Total Cost
$34,400
Indirect Cost
Name
Cedars-Sinai Medical Center
Department
Type
DUNS #
075307785
City
Los Angeles
State
CA
Country
United States
Zip Code
90048
Muhammad, A K M Ghulam; Xiong, Weidong; Puntel, Mariana et al. (2012) Safety profile of gutless adenovirus vectors delivered into the normal brain parenchyma: implications for a glioma phase 1 clinical trial. Hum Gene Ther Methods 23:271-84
Yang, J; Sanderson, N S R; Wawrowsky, K et al. (2010) Kupfer-type immunological synapse characteristics do not predict anti-brain tumor cytolytic T-cell function in vivo. Proc Natl Acad Sci U S A 107:4716-21
Lowenstein, Pedro R; Castro, Maria G (2009) Uncertainty in the translation of preclinical experiments to clinical trials. Why do most phase III clinical trials fail? Curr Gene Ther 9:368-74
Curtin, James F; Liu, Naiyou; Candolfi, Marianela et al. (2009) HMGB1 mediates endogenous TLR2 activation and brain tumor regression. PLoS Med 6:e10
Candolfi, Marianela; Yagiz, Kader; Foulad, David et al. (2009) Release of HMGB1 in response to proapoptotic glioma killing strategies: efficacy and neurotoxicity. Clin Cancer Res 15:4401-14
Candolfi, Marianela; Kroeger, Kurt M; Muhammad, A K M G et al. (2009) Gene therapy for brain cancer: combination therapies provide enhanced efficacy and safety. Curr Gene Ther 9:409-21
King, Gwendalyn D; Kroeger, Kurt M; Bresee, Catherine J et al. (2008) Flt3L in combination with HSV1-TK-mediated gene therapy reverses brain tumor-induced behavioral deficits. Mol Ther 16:682-90
King, Gwendalyn D; Muhammad, A K M Ghulam; Curtin, James F et al. (2008) Flt3L and TK gene therapy eradicate multifocal glioma in a syngeneic glioblastoma model. Neuro Oncol 10:19-31
Curtin, James F; Candolfi, Marianela; Xiong, Weidong et al. (2008) Turning the gene tap off;implications of regulating gene expression for cancer therapeutics. Mol Cancer Ther 7:439-48
Curtin, James F; Candolfi, Marianela; Puntel, Mariana et al. (2008) Regulated expression of adenoviral vectors-based gene therapies: therapeutic expression of toxins and immune-modulators. Methods Mol Biol 434:239-66

Showing the most recent 10 out of 39 publications